entertainment -WSS

entertainment

author：knowledge 2025-10-01 00:06:41 - browse：1947

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Hospital chaplains balance Covid safety with patients’ spiritual needs

WSS

Medicare Advantage overpayments discussion gets experts fired up

Medical students need to learn the potent medicine of empathy

Study suggests new cause of Down syndrome: cells linked to aging

Louisiana bill approved classifying abortion pills as controlled substances

Louisiana bill approved classifying abortion pills as controlled substances

Allen Institute goes after foundational questions, CEO Costa says

explore

entertainment

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Lawsuit challenges CMS nursing home minimum staffing rule

Dobbs anniversary: the lost opportunity of abortion as health care

Boston Scientific acquires urology company Axonics for $3.7 billion

Hollywood unions extend contract negotiations for actors

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Alkermes shareholders re

U.S. death rates show how politics are affecting public health

Hepatitis C has a cure — but many Americans still lack access to it

Pharma’s losing bet in New Jersey

focus

Boston Scientific acquires urology company Axonics for $3.7 billion

A preacher's new calling: Diversifying neuroscience research

Unmasking the 'centricity' illusion in clinical trials

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

FDA early review: GLP

Should insurance cover cosmetic surgery?

focus

entertainment

hotspot

leisure time